C102H133F6N19O8 — CID 161440949
(1S,5R)-N-[2-(3,4-dihydro-2H-chromen-2-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-4-(3-methyl-2-pyridinyl)butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(1-methylpyrazolo[4,3-b]pyridin-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-1-[[3-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-quinolin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide (PubChem CID 161440949) has the molecular formula C102H133F6N19O8 and a molecular weight of 1867.30 g/mol. Its IUPAC name is (1S,5R)-N-[2-(3,4-dihydro-2H-chromen-2-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-4-(3-methyl-2-pyridinyl)butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(1-methylpyrazolo[4,3-b]pyridin-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-1-[[3-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-quinolin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide.
| Compound Name | (1S,5R)-N-[2-(3,4-dihydro-2H-chromen-2-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-4-(3-methyl-2-pyridinyl)butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(1-methylpyrazolo[4,3-b]pyridin-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-1-[[3-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-quinolin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide |
|---|---|
| PubChem CID | 161440949 |
| Molecular Formula | C102H133F6N19O8 |
| Molecular Weight | 1867.30 g/mol |
| Exact Mass | 1866.05 |
| IUPAC Name | (1S,5R)-N-[2-(3,4-dihydro-2H-chromen-2-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-4-(3-methyl-2-pyridinyl)butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-(1-methylpyrazolo[4,3-b]pyridin-3-yl)propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1S,5R)-N-[2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]butan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-[2-methyl-1-[[3-(trifluoromethyl)-4-pyridinyl]oxy]propan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide;(1R,5S)-N-(2-quinolin-2-ylpropan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide |
| SMILES | CC(C)(CCc1ncccc1C(F)(F)F)NC(=O)C1[C@H]2CNC[C@@H]12.CC(C)(COc1ccncc1C(F)(F)F)NC(=O)C1[C@H]2CNC[C@@H]12.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)C1CCc2ccccc2O1.CC(C)(NC(=O)C1[C@H]2CNC[C@@H]12)c1ccc2ccccc2n1.Cc1cccnc1CCC(C)(C)NC(=O)C1[C@H]2CNC[C@@H]12.Cn1nc(C(C)(C)NC(=O)C2[C@H]3CNC[C@@H]23)c2ncccc21 |
| InChI | InChI=1S/C18H21N3O.C18H24N2O2.C17H22F3N3O.C17H25N3O.C16H20F3N3O2.C16H21N5O/c1-18(2,21-17(22)16-12-9-19-10-13(12)16)15-8-7-11-5-3-4-6-14(11)20-15;1-18(2,20-17(21)16-12-9-19-10-13(12)16)15-8-7-11-5-3-4-6-14(11)22-15;1-16(2,23-15(24)14-10-8-21-9-11(10)14)6-5-13-12(17(18,19)20)4-3-7-22-13;1-11-5-4-8-19-14(11)6-7-17(2,3)20-16(21)15-12-9-18-10-13(12)15;1-15(2,22-14(23)13-9-5-21-6-10(9)13)8-24-12-3-4-20-7-11(12)16(17,18)19;1-16(2,19-15(22)12-9-7-17-8-10(9)12)14-13-11(21(3)20-14)5-4-6-18-13/h3-8,12-13,16,19H,9-10H2,1-2H3,(H,21,22);3-6,12-13,15-16,19H,7-10H2,1-2H3,(H,20,21);3-4,7,10-11,14,21H,5-6,8-9H2,1-2H3,(H,23,24);4-5,8,12-13,15,18H,6-7,9-10H2,1-3H3,(H,20,21);3-4,7,9-10,13,21H,5-6,8H2,1-2H3,(H,22,23);4-6,9-10,12,17H,7-8H2,1-3H3,(H,19,22)/t12-,13+,16?;12-,13+,15?,16?;10-,11+,14?;12-,13+,15?;9-,10+,13?;9-,10+,12? |
| InChIKey | VZGNBGQMNLOXFH-XOPCRDMNSA-N |
| XLogP | 10.49 |
| TPSA | 347.51 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 135 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1867.30 |
| LogP ≤ 5 | 10.49 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 21 |